Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07527910
Recruiting
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Phase 2 · United States · 9 sites
Registry update: 29 Sept 2026
NCT07621718
Recruiting
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
Phase 3 · Austria, United Kingdom, Italy, Netherlands, United States · 25 sites
Registry update: 6 Nov 2026
NCT07460752
Recruiting
Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients
Phase 2 · United States · 1 site
Registry update: 1 Oct 2026
NCT07332741
Recruiting
FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control
Phase 2 · United States · 4 sites
Registry update: 10 Jul 2026
NCT07525206
Recruiting
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
Phase 3 · Belgium, China, Germany, Spain, Greece, Japan, South Korea, Portugal, Taiwan, United States · 94 sites
Registry update: 19 Oct 2026
NCT07567521
Recruiting
A Study of TRC003 in the Treatment of Patients With Progressive PSMA-positive mCRPC
Phase 1/2 · China · 2 sites
Registry update: 29 May 2026
NCT07531966
Recruiting
Vascular Complications After Kidney Transplantation
Not applicable · Denmark · 3 sites
Registry update: 16 Oct 2026
NCT07176546
Recruiting
TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis
Phase 2/3 · United States · 2 sites
Registry update: 2 Sept 2026
NCT07323524
Recruiting
Dapagliflozin in Active Lupus Nephritis
Phase 4 · United States · 2 sites
Registry update: 6 Nov 2026
NCT07577843
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Argentina, Austria, Australia, Belgium, Brazil, Canada, Switzerland, China, Czechia, Germany, Spain, France, United Kingdom, Greece, Hungary, Israel, India, Italy, Japan, South Korea, Malaysia, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Taiwan, United States · 295 sites
Registry update: 3 Nov 2026
NCT07677124
Recruiting
AI-Based Risk Classification and Histopathological Subtype Prediction of Basal Cell Carcinoma Using Dermoscopic Images
Not applicable · 1 site
Registry update: 30 Jun 2026
NCT06914479
Recruiting
Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors
Phase 1 · United States · 1 site
Registry update: 15 Jun 2026
NCT07602582
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Phase 3 · Japan, Puerto Rico, United States · 62 sites
Registry update: 28 Oct 2026
NCT07607418
Recruiting
Ivosidenib as Maintenance Therapy in Transplant-Ineligible IDH1-mutated AML and HR-MDS
Phase 2 · China · 1 site
Registry update: 26 May 2026
NCT07313995
Recruiting
Digital Health Intervention to Improve TPT Uptake
Not applicable · Ethiopia · 14 sites
Registry update: 25 Sept 2026
NCT07638683
Recruiting
A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).
Phase 2 · China · 1 site
Registry update: 3 Aug 2026
NCT07557849
Recruiting
Multicentric Database for KRAS Mutant Pancreatic Cancer
Not applicable · China · 1 site
Registry update: 26 May 2026
NCT07632118
Recruiting
Radiotherapy With GX Regimen as Adjuvant Therapy for High-risk Patients Following Pancreatic Cancer Surgery
Phase 3 · China · 1 site
Registry update: 8 Jun 2026
NCT07595770
Recruiting
Adebrelimab Combined With Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
Phase 2 · China · 1 site
Registry update: 19 May 2026
NCT07531745
Recruiting
ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
Phase 1/2 · Canada, United States · 7 sites
Registry update: 2 Nov 2026

Ordered by registry start date. Freshness and sponsorship never change the order.